1 completed. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Anticoagulant-induced Bleeding: new trials by email Literature Review of Anticoagulant-induced Bleeding trials Research Report on Anticoagulant-induced Bleeding
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Rivaroxaban Plus Aspirin to Manage Recurrent Venous Thromboembolic Events Rivaroxaban 20 MG [Xarelto], Aspirin 300mg, Acenocoumarol Oral Tablet - Venous Thromboembolism, Anticoagulant-induced Bleeding | Phase 2 / Phase 3 | Completed | Instituto Mexicano del Seguro Social | 58 | 2021-01-03 | 2022-08-25 |
Pulmonary Embolism (1) · Venous Thromboembolism (1) · Venous Thrombosis (1)
Cardiovascular Diseases (1) · Embolism (1) · Embolism and Thrombosis (1) · Lung Diseases (1) · Respiratory Tract Diseases (1) · Thromboembolism (1) · Thrombosis (1) · Vascular Diseases (1)
Acenocoumarol (1) · Aspirin (1) · Rivaroxaban (1) · acarboxyprothrombin (1)
Instituto Mexicano del Seguro Social (1)
Mexico (1)